Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Recombinant virus encoding one or more heterologous proteins...
Patent
1997-02-21
1998-06-23
Mosher, Mary E.
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Recombinant virus encoding one or more heterologous proteins...
4242041, 4242341, 4242691, 4242741, 4352351, 4353201, A61K 39285, A61K 39275, A61K 39002, A61K 3902, A61K 3912
Patent
active
057702128
ABSTRACT:
Defective poxviruses that lack a function imparted by an essential region of its parental poxvirus are provided for protein production and vaccination. A DNA polynucleotide encoding a protein is inserted into the defective poxvirus and placed under transcriptional control of a promoter. The defective poxvirus is viable when the lost function of the essential region is complemented by a host cell, transgenic animal or helper virus.
REFERENCES:
patent: 4722848 (1988-02-01), Paoletti et al.
patent: 5174993 (1992-12-01), Paoletti
patent: 5204243 (1993-04-01), Paoletti
patent: 5225336 (1993-07-01), Paoletti
patent: 5338683 (1994-08-01), Paoletti
patent: 5364773 (1994-11-01), Paoletti et al.
patent: 5453364 (1995-09-01), Paoletti
patent: 5494807 (1996-02-01), Paoletti et al.
patent: 5505941 (1996-04-01), Paoletti
Sutter, G. et al. Journal of Virology, vol. 68, p. 4109-4116. "Stable Expression of the Vaccinia Virus K1L Gene in Rabbit Cells Complements the Host Range Defect of a Vaccinia Virus Mutant." Jul. 1994.
Barrett et al., "Large-Scale Production and Purification of a Vaccinia Recombinant-Derived HIV-1 gp160 and Analysis of Its Immunogenicity", AIDS Research and Human Retroviruses, vol. 5, No. 2, 1989, pp. 159-171.
Boshart et al., "A Very Strong Enhancer is Located Upstream of an Immediate Early Gene of Human Cytomegalovirus", Cell, Vol. 41, Jun. 1985, pp. 521-530.
Broyles et al., "DNA-dependent ATPase Activity Associated with Vaccinia Virus Early Transcription Factor", The Journal of Biological Chemistry, vol. 263, No. 22, Aug. 1988, pp. 10761-10765.
Broyles et al., "Purification of a Factor Required for Transcription of Vaccinia Virus", The Journal of Biological Chemistry, vol. 263, nO. 22, Aug. 1988, pp. 10754-10760.
Broyles et al., "The Small Subunit of the Vaccinia Virus Early Transcription Factor Contacts the Transcription Promoter DNA", Journal of Virology, vol. 67, No. 9, Sep. 1993. pp. 5677-5680.
Chakrabarti et al., "Vaccinia Virus Expression Vector: Coexpression of .beta.-Galatosidase Provides Visual Screening of Recombinant Virus Plaques", Mol. Cell. Biol., vol. 5, No. 12, Dec. 1985, p. 3403-3409.
Condit et al., "Isolation, Characterization, and Physical Mapping of Temperature-Sensitive Mutants of Vaccinia Virus", Virology, vol. 128, 1983, p. 429-430.
Gunning et al., "A Human .beta.-actin Expression Vector System Directs High-level Accumulation of Antisense Transcripts", Proc. Natl. Acad. Sci. USA, vol. 84, Jul. 1987, pp. 4831-4835.
Hunt et al., "Conserved Features of Eukaryotic hsp70 Genes Revealed by Comparison with the Nucleotide Sequence of Human hsp70", Proc. Natl. Acad. Sci. USA, vol. 82, Oct. 1985, pp. 6455-6459.
Isaacs et al., "Reverse Guanine Phosphoribosyltransferase Selection of Recombinant Vaccinia Viruses", Virology, vol. 178, 1990, pp. 626-630.
Kane et al., "Vaccinia Virus Morphogenesis is Blocked by a Temperature-Sensitive Mutation in the 17 Gene that Encodes a Virion Component", J. of Virology, vol. 67, No. 5, May 1993, pp. 2689-2698.
M. Kriegler, "Gene Transfer and Expression, A Laboratory Manual", pp. 47-56.
Mackett et al., "Vaccinia Virus: A Selectable Eukaryotic Cloning and Expression Vector", Proc. Natl. Acad. Sci. USA, vol. 79, Dec. 1982. pp. 7415-7419.
Mann et al., "Construction of a Retrovirus Packaging Mutant and Its Use to Producce Helper-Free Defective Retrovirus", Cell, vol. 33, May 1983, pp. 153-159.
Merchlinsky et al., "Introduction of Foreign DNA into the Vaccinia Virus Genome by in Vitro Ligation: Recombination-Independent Selectable Cloning Vectors", vol. 190, 1992, pp. 522-526.
Miner et al., "Vaccinia Virus: A versatile tool for molecular biologists", TIBTECH, vol. 8, Jan. 1990, pp. 20-25.
Panicali et al., "Construction of Poxiviruses as Cloning Vectors: Insertion of the Thymidine Kinase Gene from Herpes Simplex Virus into the DNA of Infectious Vaccinia Virus", Proc. Natl. Acad. Sci. USA, vol. 79, Aug. 1992, pp. 4927-4931.
Scheiflinger et al., "Construction of Chimeric Vaccinia Viruses by Molecular Cloning and Packaging", Proc. Natl. Acad. Sci. USA, vol. 89, Nov. 1992, pp. 9977-9981.
Taylor et al., "Fowlpox Virus as a Vector in Non-avian Species", Vaccine, vol. 6, Dec. 1988, pp. 466-468.
Wigler et al., "Transfer of Purified Herpes Virus Thymidine Kinase Gene to Cultured Mouse Cells", Cell, vol. 11, May 1977, pp. 223-232.
Jindal et al., "Vaccinia Virus Infection Induces a Stress Response that Leads to Association of Hsp70 with Viral Proteins", J. of Virology, vol. 66, No. 9, Sep. 1992, pp. 5357-5362.
Fenner et al., "Vaccinia Virus as a Vector for Vaccine Antigens" The Orthopoxvirus, Chapter 12, 1988, pp. 353-377.
Falkner et al., "Transient Dominant Selection of Recombinant Vaccinia Viruses", J. of Virology, vol. 64, No. 6, Jun. 1990, pp. 3108-3111.
Falkner et al., "Escherichia coli gpt Gene Provides Dominant Selection for Vaccinia Virus Open Reading Frame Expression Vectors", J. of Virology, vol. 62, No. 6, Jun. 1988, pp. 1849-1854.
Gershon et al., "Early Transcription Factor Subunits are Encoded by Vaccinnia Virus Late Genes", Proc. Natl. Acad. Sci. USA, vol. 87, Jun. 1990, pp. 4401-4405.
Goebel et al., "The Complete DNA Sequene of Vaccinia Virus", Virology, vol. 179, 1990, pp. 247-266.
Graham et al., "Transformation of Rat Cells by DNA of Human Adenovirus 5", Virology, vol. 54, 1973, pp. 536-539.
Wittek et al., "Mapping of a Gene Coding for a Major Late Structural Polypeptide on the Vaccinia Virus Genome", J. of Virology, vol. 49, No. 2, Feb. 1984, pp. 371-378.
Weir et al., "Use of a Bacterial Expression Vector to Identify the Gene Encoding a Major Core Protein of Vaccinia Virus", J. of Virology, vol. 56, No. 2, Nov. 1985, pp. 534-540.
Lai et al., "Structural and Functional Properties of the 14-kDa Envelope Protein of Vaccinia Virus Synthesized in Escherichia coli", The J. of Biol. Chem., vol. 265, No. 36, Dec. 1990, pp. 22174-22180.
Zhang et al., "Immature Viral Envelope Formation is Interrupted at the Same State by lac Operator-Mediated Repression of the Vaccinia Virus D13L Gene and by the Drug Rifampicin", Virology, vol. 187, 1992, pp. 643-653.
Zhang et al., "Vaccinia Virus Morphogenesis is Interrupted when Expression of the Gene Encoding and 11-Kilodalton Phoshorylated Protein is Prevented by the Escherichia coli lac Repressor", J. of Virology, vol. 65, No. 11, Nov. 1991, pp. 6101-6110.
Yanisch-Perron et al., "Improved M13 Phage Cloning Vectors and Host Strains: Nucleotide Sequences of the M13mph18 and pUC19 Vectors", Gene, vol. 33, 1985, pp. 103-119.
Towbin et al., "Electrophorectic Transfer of Proteins from Polyacrylamide Gets to Nitrocellulose Sheets: Procedure and some applications", Proc. Natl. Acad. Sci. USA, vol. 76, No. 9, Sep. 1979, pp. 4350-5354.
Falkner et al., "Transient Dominant Selection of Recombinant Vaccinia Viruses", Journal of Virology, (1990), pp. 3108-3111.
Perkus et al., "Cloning and Expression of Foreign Genes in Vaccinia Virus, Using a Host Range Selection System", Journal of Virology, (1989), pp. 3829-3836.
Dorner Friedrich
Falkner Falko-Gunter
Holzer Georg
Immuno Aktiengesellschaft
Mosher Mary E.
LandOfFree
Recombinant poxviruses with foreign DNA in essential regions does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Recombinant poxviruses with foreign DNA in essential regions, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Recombinant poxviruses with foreign DNA in essential regions will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1392563